Susquehanna Fundamental Investments’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$93.4K Hold
2024
Q4
$195K Buy
2024
Q2
$861K Buy
2024
Q1
$1.11M Buy
2021
Q3
Sell
2021
Q2
$3.1M Sell
2021
Q1
$3.52M Hold
2020
Q4
$3.88M Hold
2020
Q3
$1.71M Buy
2020
Q2
$913K Buy